District Court Dismisses Case Over Abreva Advertising Claims

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

District Court Dismisses Case Over Abreva Advertising Claims

J.W. Schomisch

April 13, 2023 at 09:38 AM EST

A U.S. district court dismissed a case against GlaxoSmithKline (GSK) over advertising claims made about the company's cold sore medication Abreva. The U.S. District Court for the Northern District of California held that “plaintiffs' claims predicated on GSK's representations that Abreva is effective and can shorten the healing time and duration of symptoms are invariably pre... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

District Court Dismisses Case Over Abreva Advertising Claims

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT